Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Cash, cash equivalents and marketable ...
5don MSN
Word of the day: Acumen
Acumen is the quiet skill of seeing clearly and choosing wisely. It helps people understand situations quickly and make good ...
Expect decision regarding the advancement of an Aβ oligomer-targeted Enhanced Brain Delivery TM product candidate in early 2026 Expect to report topline results for ALTITUDE-AD, a Phase 2 study to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results